Egon Isenring1, Jan Fehr2, Nejla Gültekin3, Patricia Schlagenhauf4. 1. University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001 Zurich, Switzerland. 2. University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001 Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. 3. Centre of Competence for Military and Disaster Medicine, Federal Department of Defence, Civil Protection and Sport DDPS, Swiss Armed Forces, Armed Forces Staff, Medical Services, Worblentalstrasse 36, Ittigen, CH 3063, Switzerland. 4. University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001 Zurich, Switzerland; ESCMID Study Group for Infections in Travellers and Migrants, Switzerland. Electronic address: patricia.schlagenhauf@uzh.ch.
Abstract
BACKGROUND: In the past decade, a large influx of migrants presented in Europe. Their country of origin was mainly either Syria or Eritrea. Public health institutions in host countries in Europe are challenged to screen and care for migrant populations with regard to infectious diseases. METHODS: We performed a systematic literature review (according to PRISMA guidelines) to define the infectious disease profile of migrants originating in Syria and Eritrea. RESULTS: The search resulted in 825 papers of possible relevance for infectious diseases in migrants from Syria, of which, after screening, we included 35 in the systematic review. A further 265 papers of possible relevance for infectious diseases in Eritrean migrants were screened, of which we included 27 in the systematic review. In migrants from Syria, leishmaniasis was the most frequently reported infectious disease. In addition, colonisation with drug resistant, Gram-negativ bacteria was reported. In the Eritrean migrants the infectious disease most described in the selected papers was louse-borne relapsing fever. Other frequently reported infectious diseases were scabies and Plasmodium vivax malaria. CONCLUSION: Our systematic analysis defines the profiles of infectious diseases for migrants from Syria and Eritrea and serves as an evidence base for public health screening and care of presenting migrants.
BACKGROUND: In the past decade, a large influx of migrants presented in Europe. Their country of origin was mainly either Syria or Eritrea. Public health institutions in host countries in Europe are challenged to screen and care for migrant populations with regard to infectious diseases. METHODS: We performed a systematic literature review (according to PRISMA guidelines) to define the infectious disease profile of migrants originating in Syria and Eritrea. RESULTS: The search resulted in 825 papers of possible relevance for infectious diseases in migrants from Syria, of which, after screening, we included 35 in the systematic review. A further 265 papers of possible relevance for infectious diseases in Eritrean migrants were screened, of which we included 27 in the systematic review. In migrants from Syria, leishmaniasis was the most frequently reported infectious disease. In addition, colonisation with drug resistant, Gram-negativ bacteria was reported. In the Eritrean migrants the infectious disease most described in the selected papers was louse-borne relapsing fever. Other frequently reported infectious diseases were scabies and Plasmodium vivaxmalaria. CONCLUSION: Our systematic analysis defines the profiles of infectious diseases for migrants from Syria and Eritrea and serves as an evidence base for public health screening and care of presenting migrants.
Authors: Patricia Schlagenhauf; Martin P Grobusch; Davidson H Hamer; Hilmir Asgeirsson; Mogens Jensenius; Gilles Eperon; Camilla Rothe; Egon Isenring; Jan Fehr; Eli Schwartz; Emmanuel Bottieau; Elizabeth D Barnett; Anne McCarthy; Paul Kelly; Carsten Schade Larsen; Perry van Genderen; William Stauffer; Michael Libman; Philippe Gautret Journal: Malar J Date: 2018-11-29 Impact factor: 2.979
Authors: E Amato; L S Dansie; G M Grøneng; H S Blix; H Bentele; L Veneti; P Stefanoff; E MacDonald; H H Blystad; A Soleng Journal: Euro Surveill Date: 2019-06
Authors: Alexandra Jablonka; Christian Dopfer; Christine Happle; Andree Shalabi; Martin Wetzke; Eva Hummers; Tim Friede; Stephanie Heinemann; Nele Hillermann; Anne Simmenroth; Frank Müller Journal: NPJ Prim Care Respir Med Date: 2021-12-21 Impact factor: 2.871
Authors: Andreas Halgreen Eiset; Michaelangelo P Aoun; Ramzi S Haddad; Wadih J Naja; Kurt Fuursted; Henrik Vedel Nielsen; Christen Rune Stensvold; Monica Stougaard Nielsen; Annemarie Gottlieb; Morten Frydenberg; Christian Wejse Journal: BMJ Open Date: 2020-05-26 Impact factor: 2.692